Related Experiment Videos
Determination of extended-interval gentamicin dosing for neonatal patients in developing countries
Gary L Darmstadt1, M Monir Hossain, Atanu Kumar Jana
1Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. gdarmsta@jhsph.edu
This study identified safe and effective gentamicin dosing for neonatal sepsis in developing countries. Simplified regimens were established, showing no evidence of kidney or hearing damage in infants.
Area of Science:
- Neonatal pharmacology
- Infectious disease management
- Global health initiatives
Background:
- Infectious diseases cause 36% of global neonatal deaths.
- Developing countries face challenges in neonatal sepsis treatment.
- Optimizing gentamicin dosing is crucial for neonatal care.
Purpose of the Study:
- To determine safe and effective gentamicin dosing regimens for neonatal sepsis in developing countries.
- To simplify gentamicin administration for improved accessibility.
- To evaluate the safety and efficacy of identified dosing strategies.
Main Methods:
- 49 neonates in India and 59 in Bangladesh received tailored intravenous gentamicin doses based on weight.
- Serum gentamicin concentrations (SGC) and pharmacokinetic indices were measured.
- Renal function and infant hearing were monitored post-treatment.
Main Results:
- Most neonates achieved therapeutic peak SGC (>4 microg/mL).
- A small percentage of infants had high peak or trough SGC levels.
- No gentamicin-induced nephrotoxicity or ototoxicity was observed.
Conclusions:
- Safe and therapeutic gentamicin dosing regimens for neonatal sepsis in developing countries were established.
- The identified doses can be administered using Uniject devices for simplified delivery.
- These findings support improved management of neonatal sepsis in resource-limited settings.
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Pharmacokinetics in Pediatric Patients: Drug Excretion
Estimation of k and VD of Aminoglycosides
Drug Dosing: Infants and Children
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Dosage Interval and Administration Route: Determination Methods